Peakdale supports its customerís drug discovery activities by providing custom synthesis, contract research services and unique, patentable, drug-like molecules and intermediates, tapping relatively unexplored chemical space.
The Company achieves this by applying expertise in synthesis together with flexible resources and over a decadeís experience in innovative chemistry, utilising teams of specialists from a range of disciplines.
* Peakdale offers a unique intermediates catalogue constructed using the Companyís extensive knowledge, spanning drug discovery, synthetic, organic, analytical and medicinal chemistry.
* The Company has utilised its novel chemistry and intermediates collection to generate over 8000 lead-like screening compounds, collated and refined from over ten years of R&D. Many of these compounds have progressed through customerís clinical pipeline and are currently in clinical trials.
* The recently developed Peakexplorerô screening library includes a novel GPCR targeted range of over 1000 biologically focussed, drug-like compounds. This library was created in collaborated with De Novo Pharmaceuticals, applying their computer aided drug design expertise.
* The Company has built a reputation for delivering exclusive and confidential custom synthesis contract projects to the pharmaceutical industry to support their drug discovery activities. These projects are designed with flexibility in mind, utilising multi-disciplinary teams of experts that can adapt as the project needs change.
Based in Chapel-en-le-Frith in the UK, Peakdaleís purpose built facilities cover 3750m2 and includes parallel synthesis labs, organic research labs, an analytical department and kilo scale up labs.
Above all Peakdale values innovation and applies this principle throughout the organisation.